Table 3 Results of Logistic Regression Analysis for IFG adjusted for gender, age, BMI SDS and Country
From: Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents
OR ADA IFG | (95% CI) | OR WHO IFG | (95% CI) | |
|---|---|---|---|---|
OR for IFG, adjusted for gender, age group and BMI SDS (Ger) | ||||
Age 2–<9 y | 1.00 | ref | 1.00 | ref |
Age 9–12.9 y | 1.67 | (1.44–1.94] | 1.71 | (1.23–2.37) |
Age 13–15.9 y | 1.59 | (1.37–1.84) | 1.72 | (1.24–2.39) |
Age 16–18 y | 1.32 | (1.09–1.60) | 1.16 | (0.75–1.81) |
BMI SDS 1.8–2 | 0.64 | (0.54–0.76] | 0.66 | (0.46–0.96] |
BMI SDS 2–<2.5 | 0.61 | (0.54–0.68) | 0.58 | (0.45–0.75) |
BMI SDS 2.5–<3.0 | 0.73 | (0.64–0.82) | 0.69 | (0.54–0.89) |
BMI SDS 3.0–<4.0 | 1.00 | ref | 1.00 | ref |
Boys vs Girls (ref) | 1.24 | (1.14–1.35) | 1.21 | (1.00–1.45) |
Sweden vs Germany | 3.43 | (3.06–3.84) | 3.70 | (2.95–4.65) |
OR for IFG, adjusted for gender, age group, and BMI SDS (Swe) | ||||
Age 2–<9 y | 1.00 | ref | 1.00 | ref |
Age 9–12.9 y | 1.73 | (1.48–2.02) | 1.79 | (1.27–2.51) |
Age 13–15.9 y | 1.77 | (1.51–2.07) | 1.93 | (1.37–2.72) |
Age 16–18 y | 1.50 | (1.24–1.81) | 1.33 | (0.87–2.02) |
BMI SDS 2.3–2.5 | 1.00 | ref | 1.00 | ref |
BMI SDS 2.5–<3.0 | 1.04 | (0.94–1.14) | 1.04 | (0.80–1.34) |
BMI SDS 3.0–<3.5 | 1.20 | (1.06–1.36) | 1.15 | (0.85–1.54) |
BMI SDS 3.5–<4.0 | 1.44 | (1.25–1.66) | 1.39 | (1.00–1.93) |
BMI SDS 4.0–<4.5 | 1.54 | (1.25–1.91) | 1.74 | (1.11–2.73) |
BMI SDS >4.5 | 1.83 | (1.36–2.47) | 1.79 | (0.92–3.45) |
Boys vs Girls (ref) | 1.13 | (1.03–1.22) | 1.09 | (0.91–1.31) |
Sweden vs Germany | 3.40 | (3.04–3.81) | 3.66 | (2.92–4.60) |
